Skip to Content
Merck
  • Constitutive Interferon Attenuates RIPK1/3-Mediated Cytokine Translation.

Constitutive Interferon Attenuates RIPK1/3-Mediated Cytokine Translation.

Cell reports (2020-01-23)
Hayley I Muendlein, Joseph Sarhan, Beiyun C Liu, Wilson M Connolly, Stephen A Schworer, Irina Smirnova, Amy Y Tang, Vladimir Ilyukha, Jodie Pietruska, Soroush Tahmasebi, Nahum Sonenberg, Alexei Degterev, Alexander Poltorak
ABSTRACT

Receptor-interacting protein kinase 1 (RIPK1) and 3 (RIPK3) are well known for their capacity to drive necroptosis via mixed-lineage kinase-like domain (MLKL). Recently, RIPK1/3 kinase activity has been shown to drive inflammation via activation of MAPK signaling. However, the regulatory mechanisms underlying this kinase-dependent cytokine production remain poorly understood. In the present study, we establish that the kinase activity of RIPK1/3 regulates cytokine translation in mouse and human macrophages. Furthermore, we show that this inflammatory response is downregulated by type I interferon (IFN) signaling, independent of type I IFN-promoted cell death. Specifically, low-level constitutive IFN signaling attenuates RIPK-driven activation of cap-dependent translation initiation pathway components AKT, mTORC1, 4E-BP and eIF4E, while promoting RIPK-dependent cell death. Altogether, these data characterize constitutive IFN signaling as a regulator of RIPK-dependent inflammation and establish cap-dependent translation as a crucial checkpoint in the regulation of cytokine production.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-MLKL Antibody, clone 3H1, clone 3H1, from rat